|
John H. Dillon, II was elected to the Company’s Board of Directors and appointed to serve on the Audit Committee in November 2004. Mr. Dillon has over 35 years of experience in the healthcare and pharmaceutical industry. Before retiring at the end of 2003, Mr. Dillon held the position of Executive Vice President, Corporate Development at Auxilium Pharmaceuticals, Inc., a specialty pharmaceutical company. As Senior Vice President, Marketing of Auxilium from 2002 to 2003, he managed all pre-launch and launch activities for the company’s first commercial product, Testim®. Mr. Dillon served in marketing and business development executive positions at several companies following two decades in various positions at SmithKline Beecham Corporation, including Vice President and Director of Worldwide Business Development where he managed business development, acquisition and/or licensing, and strategic product planning, and served as principal negotiator for the global pharmaceutical business. He is a graduate of Lafayette College with a BA in History and a minor in Pre-Medical, and holds an MBA from The Wharton School at University of Pennsylvania in general management and public finance. | 